Clinical Utility of Serum Tumor Markers and Circulating Tumor Cell Assays in the Treatment of Breast Cancer

被引:2
作者
Abramson, Vandana G. [1 ]
Mayer, Ingrid A. [1 ]
机构
[1] Vanderbilt Univ, Div Hematol Oncol, Dept Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA
关键词
CARCINOEMBRYONIC ANTIGEN CEA; FOLLOW-UP; CHEMOTHERAPY; PROGRESSION; RECURRENCE; SURVIVAL; CA-15.3; BLOOD;
D O I
10.1007/s11864-011-0164-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Though serum tumor markers and circulating tumor cells (CTCs) have been available to the oncologist for many years, their place in the management of breast cancer remains unclear. Due to issues with sensitivity and specificity, tumor markers are unreliable for the detection of metastases in early stage breast cancer. For patients with metastatic breast cancer without measurable disease (e.g., bone-only disease, pleural effusions, or ascites), it is reasonable to obtain baseline values of serum tumor markers and attempt to correlate them with the first set of scans. In patients with elevated markers at baseline whose tumor marker levels decrease in correlation with an improvement in clinical symptoms, it may be reasonable to use them in conjunction with imaging to help determine whether there is progression of disease. CTCs have been found to hold strong prognostic value for breast cancer in both the early stage and metastatic settings. No large prospective studies to date, however, have shown any predictive value for CTCs and their clinical utility is therefore limited. Whether changing treatment in response to an increase in CTCs without radiologic progression results in improvements in quality of life or survival remains to be seen. CTCs hold great promise in the management of breast cancer and future studies will help delineate their role more appropriately.
引用
收藏
页码:403 / 411
页数:9
相关论文
共 36 条
[1]  
Bidard F, 2011, ANN ONCOL, V22, P41
[2]   Circulating tumor cells versus imaging - Predicting overall survival in metastatic breast cancer [J].
Budd, G. Thomas ;
Cristofanilli, Massimo ;
Ellis, Mathew J. ;
Stopeck, Allison ;
Borden, Ernest ;
Miller, M. Craig ;
Matera, Jeri ;
Repollet, Madeline ;
Doyle, Gerald V. ;
Terstappen, Leon W. M. M. ;
Hayes, Daniel F. .
CLINICAL CANCER RESEARCH, 2006, 12 (21) :6403-6409
[3]   Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease [J].
Chan, DW ;
Beveridge, RA ;
Muss, H ;
Fritsche, HA ;
Hortobagyi, G ;
Theriault, R ;
Kiang, D ;
Kennedy, BJ ;
Evelegh, M .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2322-2328
[4]   The use of blood tumour markers in the monitoring of metastatic breast cancer unassessable for response to systemic therapy [J].
Cheung, KL ;
Evans, AJ ;
Robertson, JFR .
BREAST CANCER RESEARCH AND TREATMENT, 2001, 67 (03) :273-278
[5]   Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer [J].
Cristofanilli, M ;
Hayes, DF ;
Budd, GT ;
Ellis, MJ ;
Stopeck, A ;
Reuben, JM ;
Doyle, GV ;
Matera, J ;
Allard, WJ ;
Miller, MC ;
Fritsche, HA ;
Hortobagyi, GN ;
Terstappen, LWMM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) :1420-1430
[6]   Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J].
Cristofanilli, M ;
Budd, GT ;
Ellis, MJ ;
Stopeck, A ;
Matera, J ;
Miller, MC ;
Reuben, JM ;
Doyle, GV ;
Allard, WJ ;
Terstappen, LWMM ;
Hayes, DF .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08) :781-791
[7]   Circulating Tumor Cells in Metastatic Breast Cancer From Prognostic Stratification to Modification of the Staging System? [J].
Dawood, Shaheenah ;
Broglio, Kristine ;
Valero, Vicente ;
Reuben, James ;
Handy, Beverly ;
Islam, Rabiul ;
Jackson, Summer ;
Hortobagyi, Gabriel N. ;
Fritsche, Herbert ;
Cristofanilli, Massimo .
CANCER, 2008, 113 (09) :2422-2430
[8]   Circulating Tumor Cells and [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Outcome Prediction in Metastatic Breast Cancer [J].
De Giorgi, Ugo ;
Valero, Vicente ;
Rohren, Eric ;
Dawood, Shaheenah ;
Ueno, Naoto T. ;
Miller, M. Craig ;
Doyle, Gerald V. ;
Jackson, Summer ;
Andreopoulou, Eleni ;
Handy, Beverly C. ;
Reuben, James M. ;
Fritsche, Herbert A. ;
Macapinlac, Homer A. ;
Hortobagyi, Gabriel N. ;
Cristofanilli, Massimo .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (20) :3303-3311
[9]   The follow-up of breast cancer [J].
Emens, LA ;
Davidson, NE .
SEMINARS IN ONCOLOGY, 2003, 30 (03) :338-348
[10]  
Ghossein RA, 1999, CLIN CANCER RES, V5, P1950